Dr Reddy's June qtr net surges over six-fold at Rs 4.56 bn on turnaround

Revenues grew 12% to Rs 37.21 bn due to a healthy 30% growth in domestic sales and a 16% rise in revenue contribution from emerging markets in generics

Dr Reddy's Laboratories Limited has reported more than a 6-fold increase in consolidated net profit at Rs 4.56 billion for the quarter ended June, 2018 over an exceptionally lower base of Rs 0.6 billion in the corresponding quarter previous year, on the back of a turnaround helped by a combination of revenue growth and cost control.

Revenues grew 12 per cent at Rs 37.21 billion as compared to Rs Rs 33.16 billion in the year ago period due to a healthy 30 per cent growth in Indian sales and a 16 per cent growth in revenue contribution from emerging markets led